Assessment of the diagnostic performance of the 1 mg dexamethasone suppression test in class 3 obese patients
Objective. This study was aimed to evaluate the prevalence of Cushing’s syndrome and the diagnostic performance of the 1 mg dexamethasone suppression test in class 3 obese patients.
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2022-10-01
|
Series: | Endocrine Regulations |
Subjects: | |
Online Access: | https://doi.org/10.2478/enr-2022-0028 |
Summary: | Objective. This study was aimed to evaluate the prevalence of Cushing’s syndrome and the diagnostic performance of the 1 mg dexamethasone suppression test in class 3 obese patients. |
---|---|
ISSN: | 1336-0329 |